Work

Nuances of gender affirming therapy for transgender women with spinal cord injury

Year: 2024

Type: article

Abstract: CASE DESCRIPTION: 56-year-old transgender woman with new spinal cord injury (SCI) on gender affirming hormonal therapy (GAHT) with estrogen and spironolactone. FINDINGS: After her injury, estrogen and spironolactone were discontinued, for blood clots and hypotension, respectively. Alternative options were explored. CLINICAL RELEVANCE: Little is known about GAHT in SCI for transgender women. Shared decision making should be used to navigate risks, benefits, and alternative options.

Source: Journal of Spinal Cord Medicine

DOI: 10.1080/10790268.2024.2396644

Authors: Deanna Claus, Darryl Etter, Stephanie Cowherd Ryder

Institutions: University of Colorado Anschutz, Veterans Health Administration, Denver VA Medical Center

Language: English

Topic: LGBTQ Health, Identity, and Policy

Subfield: Social Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4402191763